Bacterial contamination is invisible — but not harmless. Endotoxins (lipopolysaccharides or LPS) from gram-negative bacteria can contaminate your peptide during synthesis, purification, or storage. A single endotoxin-contaminated batch can produce spurious cell-culture results, false immune activation, and wasted time. The LAL (Limulus Amebocyte Lysate) assay is the gold-standard method for detecting and quantifying these contaminants.
Endotoxins are lipopolysaccharides (LPS) — large, complex lipid-sugar molecules that form the outer membrane of gram-negative bacteria (E. coli, Salmonella, etc.). They are not secreted toxins; they are structural components that remain in the cell wall even after the bacterium dies and is destroyed.
Where they contaminate peptides:
Cell culture toxicity: Endotoxins are pyrogenic — they trigger inflammatory responses in mammalian cells. Even at nanogram-per-milliliter concentrations, LPS can activate Toll-like receptor 4 (TLR4) on immune cells, causing release of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).
The result: Your peptide test may show apparent effects that are actually endotoxin-driven inflammation, not peptide-specific biology. This confounds interpretation and wastes research time.
In-vivo toxicity: Injected endotoxin triggers fever, shock, and organ damage. Endotoxin-contaminated peptides for animal studies can cause irreproducible or toxic results.
Detectability in solution: Endotoxins are heat-stable and survive standard sterilization (autoclaving), making them difficult to remove once present.
LAL stands for Limulus Amebocyte Lysate. It is derived from the blood cells (amebocytes) of the horseshoe crab (Limulus polyphemus). These crabs evolved a primitive but highly sensitive immune system: their blood cells have a cascade that reacts specifically and rapidly to LPS.
The mechanism:
Three LAL assay formats exist:
Cell culture applications: < 0.5 EU/mg (endotoxin units per milligram of peptide) is typical. More sensitive assays aim for < 0.1 EU/mg.
In-vivo animal studies: < 0.1 EU/mg or lower, depending on the route and species. Intravenous injection is more sensitive to endotoxin than intramuscular.
Pharmaceutical injectables (human): USP <85> standard specifies < 175 EU per container or < 175 EU / V mL (where V is container volume in mL), depending on the application.
Your Certificate of Analysis will report endotoxin as "EU/mL" (endotoxin units per milliliter of solution) if the peptide was reconstituted, or "EU/mg" if measured on the dry powder.
Example: "Endotoxin content: < 0.25 EU/mg" means the peptide batch has been tested and is below the typical research limit.
What "<" means: The assay detected no endotoxin or detected a concentration below the limit of detection. The actual endotoxin may be zero or undetectable.
A newer recombinant Factor C (rFC) assay is steadily replacing horseshoe-crab-derived LAL in pharmaceutical and research workflows. rFC uses genetically engineered Factor C protein (no animal cells), is more reproducible between batches, and addresses sustainability concerns (horseshoe-crab blood harvest). Both methods are now accepted by the FDA and European Pharmacopoeia.
Universe Peptide tests all research-grade peptides for endotoxin content and includes results on the Certificate of Analysis. Endotoxin-free assurance protects your cell culture and animal research integrity. See more in our News & research updates.